NOX
NOXOPHARM FPO [NOX]
Healthcare · ASX Small Cap
$0.0650 -1.5%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +5First seen: 2026-02-25
Score Breakdown
Technical40
Catalyst53
Sentiment50
Fundamental40
Momentum55
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- VPT accumulation divergence (bullish)
- Volatility contracting (breakout setup)
- Critical cash runway (1.1 quarters)
- Moderate P/S ratio (7.2x)
- Strong revenue growth (+40%)
- Small-cap ($20-100M)
- Strong revenue momentum (+40%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE1 (est. 2018-12-31)
Risk Signals
- MACD bearish crossover
- Price below MAs (downtrend)
- Negative 5-day momentum (-7.1%)
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-173%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Appendix 4D and FY2026 Half Year Financial Report
NONE Notice under Section 708A(5)(e) of the Corps Act
NONE Application for quotation of securities - NOX
Announcement tone +3pts
Recent ASX Announcements
| 2026-02-27 | Appendix 4D and FY2026 Half Year Financial Report PRICE SENSITIVE |
| 2026-02-26 | Notice under Section 708A(5)(e) of the Corps Act |
| 2026-02-26 | Application for quotation of securities - NOX |
| 2026-02-26 | R&D rebate strengthens cash position PRICE SENSITIVE |
| 2026-02-26 | At-the-Market (ATM) agreement with Acuity Capital PRICE SENSITIVE |
Key Metrics
$20.3M
Market Cap
280K
Avg Volume
0.8x
Vol Ratio
$0.04 — $0.14
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-157.9%
ROE
-173.1%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 62% |
| L | Leader vs Laggard | laggard | RS: -6 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #77 of 119 · Sector avg: 51
View all Healthcare signals →